Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 4/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 2/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | WHR1 | P49842 | 1/20 | 0.30 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25016612 | 1.00 | LIMK1 (0.35) | LIMK1ALOX5PIM1PIM2PIM3 | |
| SCHEMBL25016611 | 0.99 | ALOX5 (0.36) | LIMK1ALOX5PIM1PIM2PIM3 | |
| SCHEMBL22195961 | 0.96 | LIMK1 (0.35) | LIMK1ALOX5PIM1PIM2PIM3 | |
| SCHEMBL22196133 | 0.95 | LIMK1 (0.34) | LIMK1ALOX5PIM1PIM2PIM3 | |
| SCHEMBL22330288 | 0.95 | LIMK1 (0.34) | LIMK1ALOX5PIM1PIM2PIM3 | |
| SCHEMBL22330131 | 0.94 | LIMK1 (0.37) | LIMK1ALOX5PIM1PIM2PIM3 | |
| SCHEMBL22329296 | 0.94 | LIMK1 (0.37) | LIMK1ALOX5PIM1PIM2PIM3 | |
| SCHEMBL22329602 | 0.94 | LIMK1 (0.38) | LIMK1ALOX5PIM1PIM2MEN1 | |
| SCHEMBL25018088 | 0.94 | ALOX5 (0.43) | LIMK1ALOX5MEN1KMT2AATM | |
| SCHEMBL25016609 | 0.94 | ALOX5 (0.38) | LIMK1ALOX5PIM1PIM2PIM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578076-B2 | Heterocyclic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| US-11581494-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| US-20200259098-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578076-B2 | Heterocyclic compound and organic light emitting device using the same | CYBA, SUN2, TMEM109 | LIMK1 389/4885ALOX5 366/4885PIM1 2726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.